fenclonine has been researched along with Cancer of ILEUM in 2 studies
Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Häussinger, D | 1 |
| Koch, HK | 1 |
| Köttgen, E | 1 |
| Fröhlich, J | 1 |
| Gerok, W | 1 |
| Bates, GJ | 1 |
| Luscombe, FE | 1 |
2 other studies available for fenclonine and Cancer of ILEUM
| Article | Year |
|---|---|
[The carcinoid syndrome. A case description with special reference to its therapeutic aspects].
Topics: Carcinoid Tumor; Fenclonine; Humans; Ileal Neoplasms; Malignant Carcinoid Syndrome | 1982 |
Carcinoid metastasis in the middle ear: anaesthetic and surgical management.
Topics: Carcinoid Tumor; Cyproheptadine; Ear Neoplasms; Ear, Middle; Fenclonine; Humans; Ileal Neoplasms; Ke | 1989 |